HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comfort Boateng Selected Research

CAB2-015

11/2017The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Comfort Boateng Research Topics

Disease

1Opioid-Related Disorders (Opiate Addiction)
11/2017
1Opportunistic Infections (Opportunistic Infection)
01/2013

Drug/Important Bio-Agent (IBA)

1Dopamine D3 ReceptorsIBA
11/2017
1CAB2-015IBA
11/2017
1Opioid Analgesics (Opioids)IBA
11/2017
1Pharmaceutical PreparationsIBA
11/2017
1BAK4-54IBA
11/2017
1LigandsIBA
11/2017
1Oxycodone (Oxycontin)FDA LinkGeneric
11/2017
1IodidesIBA
01/2013

Therapy/Procedure

1Self Administration (Administration, Self)
11/2017